Antibalder
Research-use capsule against hair loss that combines minoxidil and the peptide GHK-Cu; the combination has not been studied in humans.

DETAILED OVERVIEW
What is Antibalder?
Antibalder is a research-use capsule that combines two hair-loss ingredients: minoxidil and GHK-Cu, a short protein chain (peptide) bound to copper. The combination is not approved as a medicine anywhere, although oral minoxidil on its own is prescription-only.
Minoxidil widens blood vessels, increases the blood supply of the hair follicle and lengthens the growth phase of the hair. In lab experiments GHK-Cu boosted the growth of human hairs. Each ingredient has been studied extensively on its own, but the effect and safety of the combination itself have not been studied in humans. Oral minoxidil can cause fluid retention, a racing heartbeat and unwanted body and facial hair growth. It must not be used after a recent heart attack, with active heart-muscle circulation problems, or in pregnancy and breastfeeding, and its use generally calls for medical supervision.
Type
Fixed-dose oral combination (research capsule)
Components
GHK-Cu (copper tripeptide-1 complex) + Minoxidil
Structure
GHK-Cu: Gly-His-Lys · Cu²⁺ + Minoxidil: piperidinopyrimidine
GHK-Cu
CAS 89030-95-5 · C₁₄H₂₄CuN₆O₄ · ~403.92 g/mol
Minoxidil
CAS 38304-91-5 · C₉H₁₅N₅O · ~209.25 g/mol
Molecular weight
GHK-Cu ~403.92 · Minoxidil ~209.25 g/mol
This stack contains the following peptides
No anecdote collected yet.
Data console
Lab data
Pickart L, Margolina A. . Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987..
Pickart L, Vasquez-Soltero JM, Margolina A. . GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108..
Pyo HK, Yoo HG, Won CH, et al. . The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839..
Perera E, Sinclair R. . Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Research. 2017;6:1650..
Suchonwanit P, Thammarucha S, Leerunyakul K. . Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786..
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. . Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651..
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Fluid retention and edema (oral minoxidil component): sodium and water retention, ankle or facial swelling, weight gain; more pronounced at higher systemic exposure.
- Reflex tachycardia and palpitations: vasodilation can trigger a compensatory rise in heart rate, which may worsen angina.
- Hypertrichosis (unwanted body and facial hair): the most common reason for stopping systemic minoxidil, more pronounced in women.
- Initial paradoxical shedding (telogen effluvium): a transient increase in hair loss in the first weeks before regrowth begins, not a treatment failure.
- GHK-Cu component: the copper tripeptide is generally well tolerated; a theoretical concern is prolonged high copper intake (monitoring copper balance is reasonable with long-term use).
- Combination uncertainty: the fixed GHK-Cu + oral minoxidil combo has not been studied for human safety or pharmacokinetics on its own; risk is inferred from the components.
Contraindications · 5
- Pheochromocytoma: oral minoxidil may provoke catecholamine release and is therefore contraindicated.
- Acute myocardial infarction, active ischemia or significant pericardial effusion: reflex tachycardia and increased cardiac workload contraindicate oral minoxidil.
- Pregnancy and breastfeeding: minoxidil is excreted in breast milk and fetal safety is not established; not justified for alopecia.
- Known hypersensitivity to minoxidil, GHK-Cu or any excipient, or Wilson's disease / copper-metabolism disorder (due to the copper content).
- Unsupervised self-treatment: because of oral minoxidil's systemic effects (blood pressure, heart rate, fluid balance) the fixed oral combo is not advised without monitoring.
Related Hair & Skin
Same therapeutic category
Studies
Related research and clinical findings
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A.
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Vasquez-Soltero JM, Margolina A.
The effect of tripeptide-copper complex on human hair growth in vitro
Pyo HK, Yoo HG, Won CH, et al.
Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study
Perera E, Sinclair R.
Minoxidil and its use in hair disorders: a review
Suchonwanit P, Thammarucha S, Leerunyakul K.
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al.
Telegram
Have a question about Antibalder?
Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.